Invenomic Capital Management’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-67,739
Closed -$4.27M 173
2024
Q1
$4.27M Buy
67,739
+9,038
+15% +$545K 0.23% 103
2023
Q4
$3.49M Sell
58,701
-296,489
-83% -$16.2M 0.16% 122
2023
Q3
$16M Buy
355,190
+171,591
+93% +$6.98M 0.67% 48
2023
Q2
$6.84M Sell
183,599
-18,333
-9% -$734K 0.35% 74
2023
Q1
$7.93M Sell
201,932
-307,471
-60% -$12.1M 0.45% 65
2022
Q4
$15.9M Buy
509,403
+394,200
+342% +$14.5M 1.08% 26
2022
Q3
$4.84M Sell
115,203
-202,261
-64% -$8.15M 0.42% 78
2022
Q2
$12.9M Buy
317,464
+50,857
+19% +$1.88M 0.92% 33
2022
Q1
$9.69M Sell
266,607
-110,618
-29% -$3.67M 1.03% 27
2021
Q4
$12.6M Buy
377,225
+128,022
+51% +$4.42M 2.69% 2
2021
Q3
$8.96M Sell
249,203
-29,868
-11% -$980K 2.91% 3
2021
Q2
$8.97M Buy
279,071
+93,000
+50% +$2.77M 2.15% 4
2021
Q1
$5.6M Sell
186,071
-32,516
-15% -$844K 1.25% 11
2020
Q4
$4.64M Buy
218,587
+114,787
+111% +$2.85M 1.18% 9
2020
Q3
$2.73M Sell
103,800
-88,117
-46% -$3.41M 1.51% 14
2020
Q2
$5.23M Sell
191,917
-28,463
-13% -$685K 3.87% 1
2020
Q1
$4.16M Buy
+220,380
New +$4.07M 3.4% 1

Other funds holding LRN